1 / 22

Soluble chemical markers of gastrointestinal and pancreatic tumors

Soluble chemical markers of gastrointestinal and pancreatic tumors. Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health Science Center/Jacksonville. Leading causes of death in the United States. Source: http://www.cdc.gov (1995 data).

bisa
Download Presentation

Soluble chemical markers of gastrointestinal and pancreatic tumors

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Soluble chemical markers of gastrointestinal and pancreatic tumors Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health Science Center/Jacksonville

  2. Leading causes of death in the United States Source: http://www.cdc.gov (1995 data)

  3. Causes of cancer deaths in the United States Source: CA Cancer J Clin 46:1996

  4. Incidence and mortality of GI/pancreatic tumors (1996 estimates) Source: CA Cancer J Clin 46:1996

  5. Colorectal cancer • Vast majority of cases are adenocarcinomas • Begins with adenomatous polyps • Molecular biology • Point mutations in ras proto-oncogene on chromosome 12 • p53 deletion (chromosome 17) • “DCC” gene deletion (chromosome 18) • “MCC” gene mutation (chromosome 5) • “APC” gene mutation (chromosome 5)

  6. Chemical markers of colorectal cancer • Carcinoembryonic antigen (CEA) • High molecular weight alkaline phosphatase • Mucin CA M43 • K-ras mutation

  7. Carcinoembryonic antigen • Oncofetal antigen expressed in gut, pancreas, and liver • MW 150-300 kD; 50% carbohydrate • Normally, production disappears after birth • Elevated in 60-90% of colorectal cancers • False elevations due to cirrhosis, emphysema, colitis • Most useful for clinical staging, detecting recurrence

  8. Chemical markers of colorectal cancer • Carcinoembryonic antigen (CEA) • High molecular weight alkaline phosphatase • Mucin CA M43 • K-ras mutation

  9. High molecular weight alkaline phosphatase • Also called the “fast liver” fraction • Is more sensitive for cholestasis than liver ALP • In patients with histologically-verified colorectal cancers: • Sensitivity = 63% • Specificity = 89% • In conjunction with CEA • Sensitivity = 72% • Specificity = 87%

  10. Chemical markers of colorectal cancer • Carcinoembryonic antigen (CEA) • High molecular weight alkaline phosphatase • Mucin CA M43 • K-ras mutation

  11. CA M43 • Mucin antigen • Using a two-site solid phase immunoassay: • Sensitivity = 42% • Specificity = 97% • Positive predictive value = 98% • In combination with CEA, sensitivity is slightly improved

  12. Chemical markers of colorectal cancer • Carcinoembryonic antigen (CEA) • High molecular weight alkaline phosphatase • Mucin CA M43 • K-ras mutation

  13. K-ras mutation • Point mutations in the ras family of oncogenes have been described in several malignancies • K-ras mutations at codons 12 and 13 • Most common mutation is Gly-12 to Val-12 • Found in 39-47% of colorectal tumors • Method improvements • Competitive allele-specific oligonucleotide hybridization • Mutant-enriched PCR

  14. Pancreatic cancer • 90% are exocrine, most commonly in the head of the organ • 75% of ductal adenocarcinomas secrete mucin • Clinically silent until it reaches advanced stage • Lung, liver metastases • One-year survival is 8-10% • Five-year survival is 2%

  15. Chemical markers of pancreatic cancer • CA 19-9 • TPS • CAM 17.1

  16. CA 19-9 • Sialylated Lexa • Secreted by gastric, colonic, endometrial, and salivary epithelia • Lea-b- individuals (5%) do not make Ca 19-9 • Clinical performance • Sensitivity = 80% • Specificity = 60-100% (depending on control group) • Low positive predictive value in a screening scenario

  17. Chemical markers of pancreatic cancer • CA 19-9 • TPS • CAM 17.1

  18. TPS • Specific epitope of tissue polypeptide antigen (TPA) • Nonspecific marker of cellular proliferation • Sensitivity is nearly 100% for detecting pancreatic cancer • Specificity, as expected, is low

  19. Chemical markers of pancreatic cancer • CA 19-9 • TPS • CAM 17.1

  20. CAM 17.1 • Immunoglobulin M antibody with high specificity for intestinal mucus • Epitope is a sialylated blood group antigen (probably I) • Sensitivity = 67% in patients with diagnosed pancreatic cancer (correlated with stage) • Specificity • 100% in healthy volunteers • 80% in gastric cancer patients

  21. Stomach cancer • At one time, the most common cause of cancer death in men • Death rate in U.S. has dropped nearly 80% since 1930 • Reason for decline is unknown • 95% are adenocarcinoma originating in mucous cells • Most are discovered after penetrating into the muscularis • Metastases are common • 20% ten-year survival if advanced • “Early gastric cancer” (confined to mucosa or submucosa)

  22. “He uses statistics as a drunken man uses lamp posts -- for support rather than illumination.” Andrew Lang (1844-1912)

More Related